Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs

BACKGROUND: Since the introduction of the orphan drugs legislation in Europe, it has been suggested that the general method of assessing drugs for reimbursement is not necessarily suitable for orphan drugs. The National Institute for Health and Clinical Excellence indicated that several criteria oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Schey, C., Krabbe, P. F. M., Postma, M. J., Connolly, M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240262/
https://www.ncbi.nlm.nih.gov/pubmed/28095876
http://dx.doi.org/10.1186/s13023-016-0555-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240262/
https://www.ncbi.nlm.nih.gov/pubmed/28095876
http://dx.doi.org/10.1186/s13023-016-0555-3

Ejemplares similares